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Activation of renal signaling pathways in db/db mice with type growth factors, it is now evident that metabolic and phys-
2 diabetes. ical factors such as hyperglycemia, osmolality, and stretch
Background. Altered regulation of signaling pathways may also activate signaling pathways and elicit phenotypiccontribute to the pathogenesis of renal disease. We examined
changes in target tissues [1, 2]. Elevation of ambientrenal cortical signaling pathways in type 2 diabetes.
plasma glucose concentration is a primary pathogeneticMethods. The status of renal cortical signaling pathways was
examined in control and db/db mice with type 2 diabetes in factor in microvascular complications in both type 1 and
the early phase of diabetic nephropathy associated with renal type 2 diabetes mellitus [3, 4]. The primacy of glucose
matrix expansion and albuminuria. in diabetic complications has led to studies on regulationResults. Tyrosine phosphorylation of renal cortical proteins
of signaling by glucose in several tissues. In the kidney,was increased in diabetic mice. Renal cortical activities of phos-
a major site of microvascular complications, glomerularphatidylinositol 3-kinase (PI 3-kinase) in antiphosphotyrosine
immunoprecipitates, Akt (PKB), and ERK1/2-type mitogen- activity of protein kinase C (PKC) is increased in rats
activated protein (MAP) kinase activities were significantly with streptozotocin-induced type 1 diabetes [5, 6]. Incre-
augmented sixfold (P  0.01), twofold (P  0.0003), and sev-
ment in composite PKC activity involved activation ofenfold (P  0.001), respectively, in diabetic mice compared
PKC [7], although an increase in activities of otherwith controls. A part of the increased renal cortical PI 3-kinase
activity was due to insulin receptor activation, as PI 3-kinase isoenzymes of PKC is also reported [8]. Among other
activity associated with  chain of the insulin receptor was signaling molecules, the activities of Erk1/2-type mito-
increased nearly fourfold (P 0.0235). Additionally, the kinase gen-activated protein (MAP) kinase (ERK) and its up-
activity of the immunoprecipitated insulin receptor  chain
stream regulator, MEK, are augmented in glomeruli ofwas augmented in the diabetic renal cortex, and tyrosine phos-
rat with type 1 diabetes [9]. Increased ERK activity ap-phorylation of the insulin receptor was increased. In the liver,
activities of PI 3-kinase in the antiphosphotyrosine immuno- pears to be partly due to reduction in the activity of
precipitates and Akt also were increased threefold (P  0.05) MAPK phosphatase-1 (MKP-1), and in vitro studies sug-
and twofold (P  0.0002), respectively. However, there was gest that MAPK activation is PKC dependent [9, 10].no change in the hepatic insulin receptor-associated PI 3-kinase
Increased PKC activity in renal tissue has functionalactivity. Additionally, the hepatic ERK1/2-type MAP kinase
implications as LY333531, a PKC-specific inhibitor, re-activity was inhibited by nearly 50% (P  0.01).
Conclusions. These studies demonstrate that a variety of verses the increase in both glomerular filtration rate and
receptor signaling pathways are activated in the renal cortex microalbuminuria in rats with type 1 diabetes [6].
of mice with type 2 diabetes, and suggest a role for augmented Similar to type 1 diabetes, activation of glomerularinsulin receptor activity in nephropathy of type 2 diabetes.
PKC occurs in mice with type 2 diabetes [11]. However,
the administration of LY333531 resulted in partial ame-
Altered regulation of signaling pathways is gaining lioration of functional abnormalities such as albumin-
increasing recognition as an important mechanism in the uria, despite the complete reversal of glomerular PKC
pathogenesis of renal disease. In addition to soluble activation [11]. It is likely that in addition to PKC, other
signaling pathways are also involved in pathogenesis of
renal disease in type 2 diabetes. Notwithstanding theKey words: diabetic nephropathy, insulin receptor, phosphotidylinosi-
tol 3-kinase, MAP kinase, Akt, receptor signaling, renal cortex. similarity in activation of renal tissue PKC in type 1 and
type 2 diabetes, emerging observations suggest that atReceived for publication September 6, 2000
least some of the pathogenetic mechanisms of renal dis-and in revised form February 7, 2001
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diabetes is associated with an increase in glomerular 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 2g/mL
aprotinin, and 1 g/mL leupeptin. The homogenateslaminin mRNA levels [12]. However, in type 2 diabetes,
augmented renal laminin content is accompanied by a were centrifuged at 10,000  g for 30 minutes. Cleared
supernatants were collected, and protein content was esti-significant decrease in the mRNA levels, suggesting that
nontranscriptional mechanisms lead to increased laminin mated. Equal amounts of cleared supernatant (150 g)
from control and diabetic mice were separated on 8%accumulation in type 2 diabetes [13]. Differences in regu-
lation of renal transforming growth factor-1 (TGF-1) sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (SDS-PAGE). The proteins were transferred tobetween type 1 and type 2 diabetes have also been re-
ported. Transcripts of TGF-1 are increased in the glo- nitrocellulose membrane overnight and were blocked for
an hour in 5% nonfat dry milk. Following washes in Tris-meruli of rodents with type 1 and type 2 diabetes [14, 15].
However, TGF-1 mRNA levels in the tubulointerstit- buffered saline containing 0.1% Tween-20, the membrane
was incubated with a 1:1000 dilution of an antiphosphoty-ium are increased only in type 1 diabetes, remaining
unchanged in type 2 diabetes [15, 16]. These data raise rosine antibody linked to horseradish peroxidase (RC20;
Transduction Laboratories, Lexington, KY, USA) forthe possibility that pathogenetic mechanisms leading to
matrix expansion or manifestations of diabetic nephrop- three hours. The membranes were then washed, and the
reactive bands were detected by chemiluminescence usingathy may be differentially regulated in the two types of
diabetes. As type 2 diabetes is a hyperinsulinemic state, it the ECL system (Amersham, Buckinghamshire, UK).
is also possible that altered regulation of insulin receptor
Phosphatidylinositol 3-kinase assaysignaling contributes to renal disease. This study exam-
ined the status of signaling pathways, including that of Renal cortical sections or liver fragments were homog-
enized in the RIPA buffer consisting of 20 mmol/L Trisinsulin receptor, in the renal cortex of db/db mice with
type 2 diabetes. (pH 7.5), 150 mmol/L sodium chloride, 5 mmol/L EDTA,
0.1 mmol/L sodium orthovanadate, 1 mmol/L PMSF, 0.1%
aprotinin, and 1% NP-40. Equal amounts of homoge-
METHODS
nates from control and diabetic mice (500 g) were used
Animal model of type 2 diabetes for immunoprecipitation with antiphosphotyrosine anti-
body or antibody against the  chain of insulin receptor,The db/db mouse strain was used as a model of type 2
diabetes and its lean littermate as the control (Jackson as previously described [20]. Immunoprecipitates were
incubated with 10 g phosphatidylinositol (PI) forLabs, Bar Harbor ME, USA). The db/db mice have an
inactivating mutation in the leptin receptor gene (lpr), 10 minutes at room temperature in phosphatidylinositol
3-kinase (PI 3-kinase) assay buffer containing 20 mmol/Lresulting in a shorter intracellular domain of the receptor
that is unable to transduce signals [17]. Their phenotype Tris (pH 7.5), 100 mmol/L sodium chloride, and 0.5 mmol/L
EDTA. After the addition of 20 mmol/L magnesiumconsists of obesity, insulin resistance, and diabetes, simi-
lar to type 2 diabetes in humans [18]. We have recently chloride and 5 Ci [32P]-adenosine triphosphate (ATP)
to the assay mixture, the reaction was carried out fordescribed the renal functional and histologic abnormali-
ties in the db/db mice [13]. In the present study, lean another ten minutes at room temperature. The reaction
was stopped by the addition of a mixture of chloroform-littermate control and diabetic mice were studied in the
early phase of diabetes (within 2 to 4 weeks of onset). methanol and 11.6 N HCl at a ratio of 50:100:1. Lipids
were extracted with 100 L of chloroform, and the or-At this time, the db/db mice have elevated plasma glu-
cose levels in the range of 30 mmol/L, and urinary albu- ganic layer was washed with methanol and 1 N HCl in
a 1:1 ratio. Reaction products were dried, resuspendedmin excretion corrected for urinary creatinine is signifi-
cantly elevated [13]. Renal histology examined by silver in chloroform, separated by thin layer chromatography
employing chloroform/methanol/28% ammonium hy-methanamine and periodic acid-Schiff stains shows
expansion of extracellular matrix as well as augmented droxide/water in a ratio of 129:114:15:21. The spots were
visualized by autoradiography. Laser densitometry waslaminin chain content [13]. The db/db mice develop pro-
gressive renal histologic changes and functional derange- performed to assess the density of the reactant bands.
ments, including loss of renal function, similar to humans
Insulin receptor immunokinase assaywith type 2 diabetes [19]. Experiments were performed
on individual mice from two separate batches. Equal amounts (500 g) of renal cortical homogenates
from control and diabetic mice were suspended in the
Tyrosine phosphorylation of proteins RIPA buffer containing of 0.1 mmol/L sodium orthovan-
adate and were immunoprecipitated with a rabbit poly-Renal cortical sections were homogenized in a buffer
made of 50 mmol/L Tris (pH 7.2), 100 mmol/L sodium clonal antibody against insulin receptor  chain (Santa
Cruz Laboratories, Santa Cruz, CA, USA) in the pres-chloride, 1% NP-40, 2 mmol/L ethylenediaminetetraace-
tic acid (EDTA), 0.1 mmol/L sodium orthovanadate, ence of protein A-Sepharose beads. The immunobeads
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were suspended in 20 L of a kinase buffer containing of [32P] ATP in MAP kinase buffer, which contained
10 mmol/L HEPES (pH 7.4), 10 mmol/L magnesium50 mmol/L HEPES (pH 7.4) and 10 mmol/L manganese
chloride. Reaction was initiated by adding 5 Ci of [32P] chloride, 0.5 mmol/L DTT, and 0.1 mmol/L sodium or-
thovanadate for 30 minutes at 30C. After the additionATP. After an incubation of 30 minutes at 30C, the
reaction was stopped by adding an equal volume of 2  of an equal volume of 2  sample buffer and boiling,
phosphorylated MBP was resolved by SDS-PAGE andsample buffer. Phosphorylated proteins were resolved
on 7.5% SDS-PAGE and autoradiographed. was autoradiographed. Western blotting with anti–ERK-1
antibody was performed on an aliquot of assay lysates
Tyrosine phosphorylation of insulin receptor to assess loading. The density of the reactant bands was
assessed by laser densitometry.Equal amounts (1 mg) of renal cortical homogenates
were immunoprecipitated with a specific antibody against
Statisticsinsulin receptor  chain (Santa Cruz Laboratories). The
immunoprecipitates were separated by 7.5% SDS-PAGE Data were expressed as means and standard error
(SEM), and comparisons were made by the Student t test;and transferred to a nitrocellulose membrane overnight.
After blocking in 5% nonfat dry milk, the membrane P  0.05 was considered significant.
was washed three times in Tris-buffered saline containing
0.1% Tween-20 and probed with 1:2000 dilution of a
RESULTS
mouse monoclonal antibody against phosphotyrosine
Tyrosine phosphorylation of renal cortical proteins is(Upstate Biotechnology, Lake Placid, NY, USA). The
increased in type 2 diabeteslatter was detected by an antibody against mouse IgG
that was linked to horseradish peroxidase. The reactive Increased tyrosine phosphorylation of cellular proteins
has been shown to mediate effects of hormones and growthbands were detected by chemiluminescence. The mem-
brane was stripped and immunoblotted with the antibody factors and occurs as a result of activation of tyrosine
kinases. We thus examined tyrosine phosphorylation ofagainst insulin receptor  chain to assess loading of sam-
ples and to ascertain the identity of the immunoprecipi- proteins in renal cortical homogenates as an early event
in signaling cascade activation in type 2 diabetes. Figuretated band.
1 illustrates that tyrosine phosphorylation of proteins of
Akt/PKB kinase assay approximately 190, 95, 85, and 60 kD was increased in
the renal cortex of mice with diabetes. These bands mayAkt was immunoprecipitated from equal amounts
(500 g) of renal cortical and liver homogenates from correspond to insulin receptor substrate (IRS)-1 or -2,
insulin receptor  chain, p85 subunit of PI 3-kinase, andcontrol and diabetic mice at 4C for three hours. Protein
G sepharose beads were added and incubated at 4C for SH-PTP1 phosphatase, respectively. Western blotting
showed that IRS-2 rather than IRS-1 was present in theone hour. The beads were washed three times in RIPA
buffer and two times in phosphate-buffered saline (PBS) murine renal cortex. To determine whether the apparent
increase in tyrosine phosphorylation was due to an in-and were resuspended in Akt buffer containing 50 mmol/L
Tris (pH 7.4), 10 mmol/L magnesium chloride, 25 mmol/L crease in tyrosine phosphorylation of the individual pro-
tein or an increase in the amount of the protein with a-glycerophosphate, 1 mmol/L dithiothreitol (DTT), and
0.1 mmol/L sodium orthovanadate. The Akt assay was basal degree of tyrosine phosphorylation, IRS-2 (190
kD) was used as an index protein to assess changes.performed in the presence of 50 mol/L of ATP, 1 Ci
of [32P]-ATP, and 5 g myelin basic protein (MBP) at Immunoblotting of renal cortical homogenates did not
reveal significant changes in the amount of IRS-2 be-30C for 30 minutes. The reaction was stopped by the
addition of an equal volume of 2  sample buffer. Phos- tween control and diabetic mice (Fig. 1B). These data
suggest that tyrosine phosphorylation of individual pro-phorylated bands were detected by SDS-PAGE followed
by autoradiography. Western blotting with an anti-Akt/ teins is augmented in the renal cortex of diabetic mice.
PKB antibody (Upstate Biotechnology) was performed
PI 3-kinase activity is increased in the renal cortexon an aliquot of the assay lysates to assess the loading.
and liver of diabetic mice
ERK1/2-type MAP kinase assay Increased tyrosine phosphorylation of a number of
proteins in the renal cortex of diabetic mice suggestsEqual amounts (500 g) of renal cortical or liver ho-
mogenates from control and diabetic mice were incu- initiation of different signaling cascades. PI 3-kinase is
one of the downstream targets of increased tyrosine ki-bated with a rabbit polyclonal anti ERK-1 antibody
(Santa Cruz Laboratories) for two hours at 4C. The nase activity. PI 3-kinase regulates glucose transport in
skeletal muscle and adipose tissue [21] and is likely toantibody also detects ERK-2 MAP kinase. The ERK
assay was performed in the presence of 0.5 mol/L pro- be involved in pathogenesis of diabetic renal disease.
Since its activity is regulated by tyrosine phosphoryla-tein kinase A inhibitor, 25 mol/L of cold ATP, 1 Ci
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Fig. 1. Tyrosine phosphorylation of renal cor-
tical proteins is increased in db/db mice with
type 2 diabetes. (A) Equal amounts (150 g)
of renal cortical homogenates from control
(C) and diabetic (D) mice were fractionated
on an 8% SDS polyacrylamide gel and trans-
ferred to a nitrocellulose membrane over-
night. Following blocking with 5% nonfat dry
milk, the membrane was incubated with a 1:1000
dilution of peroxidase-linked antiphosphotyro-
sine antibody for three hours. The membrane
was washed and developed by chemilumines-
cence. A representative blot from two experi-
ments is shown. (B, upper panel) Equal amounts
(150 g) of renal cortical homogenates from
control and diabetic mice were fractionated
on a 8% SDS polyacrylamide gel and trans-
ferred to a nitrocellulose membrane overnight.
Following blocking with 5% nonfat dry milk,
the membrane was incubated with 1 g/mL
of a rabbit antibody against IRS-2 (Santa Cruz
Biotechnology) for three hours followed by
incubation with 1:10,000 dilution of peroxi-
dase-linked anti-rabbit antibody for one hour.
The membrane was washed, and the bands
were developed by chemiluminescence. Mo-
lecular weight marker is shown. (Lower panel)
The membrane was also probed with 1:10,000
dilution of rabbit anti-actin antibody for three
hours, followed by incubation with the second-
ary antibody as described previously in this arti-
cle. Molecular weight marker is shown.
Fig. 2. Phosphatidylinositol 3-kinase (PI 3-kinase)
activity in antiphosphotyrosine immunopre-
cipitates in the renal cortex of db/db mice with
type 2 diabetes. (A) Equal amounts (500 g)
of renal cortical homogenates from control and
diabetic mice were immunoprecipitated with an
antiphosphotyrosine antibody. PI 3-kinase ac-
tivity in the immunoprecipitates was deter-
mined in the presence of PI and [32P]ATP as
described in the Methods section. Each lane
represents data from an individual animal. A
representative chromatograph is shown. PI 3-P
refers to phophatidylinositol 3-phosphate. (B)
Densitometric analysis of phosphorylated PI
3-P from two independent experiments with
a total of nine control and nine diabetic mice.
Data are expressed as fold-stimulation over
control (mean  SEM, *P  0.01).
tion, we measured PI 3-kinase activity in antiphosphotyr- Activation of insulin receptor in the renal cortex of
diabetic miceosine immunoprecipitates from renal cortex of control
and diabetic mice. Figure 2 shows that phosphotyrosine- Type 2 diabetes is associated with elevated levels of
associated PI 3-kinase activity was significantly increased plasma insulin owing to resistance to glucose transport
by nearly sixfold in renal cortex of diabetic mice (P  actions of insulin in tissues such as the liver and the
0.01). We then examined the status of PI 3-kinase in skeletal muscle. It is unclear whether other tissues, in-
diabetic liver and compared its regulation with that in cluding the kidney, manifest resistance to insulin in type
the kidney (Fig. 3). In the liver, a seat of insulin resistance 2 diabetes. Activation of the insulin signaling pathway
in type 2 diabetes [22], phosphotyrosine-associated PI may be employed as an index of insulin sensitivity. We
3-kinase activity was augmented threefold compared assayed for PI 3-kinase activity in immunoprecipitates
with control mice (P  0.05; Fig. 3). Thus, PI 3-kinase of insulin receptor  chain in the renal cortical tissue
activity is augmented in both the renal cortex and the from control and diabetic mice. This assay depends on
the association of cytoplasmic domain of insulin receptorliver of db/db mice.
Feliers et al: Renal signaling in type 2 diabetes 499
Fig. 3. PI 3-kinase activity in antiphosphoty-
rosine immunoprecipitates in the liver of db/db
mice with type 2 diabetes. (A) Equal amounts
(500 g) of liver homogenates from control
and diabetic mice were immunoprecipitated
with an antiphosphotyrosine antibody. PI
3-kinase activity was measured in the immuno-
precipitates, as described in Figure 2. Each lane
represents data from an individual animal. A
representative chromatograph is shown. (B)
Densitometric analysis of phosphorylated phos-
phatidyl-inositol 3-phosphate (PI 3-P) from two
independent experiments with a total of six
control and seven diabetic mice. Data are ex-
pressed as fold-stimulation over control (mean 
SEM, *P  0.05).
Fig. 4. PI 3-kinase activity in the insulin recep-
tor  chain immunoprecipitates in the renal
cortex of db/db mice with type 2 diabetes.
(A) Equal amounts (500 g) renal cortical
homogenates from lean litter control and dia-
betic mice were immunoprecipitated with an
antibody against  chain of the insulin recep-
tor. PI 3-kinase activity was measured in the
immunoprecipitates, as described in Figure 2.
Each lane represents an individual animal. A
representative chromatograph is shown. (B)
Densitometric analysis of phosphorylated phos-
phatidylinositol 3-phosphate (PI 3-P) from two
independent experiments with a total of seven
control and eight diabetic mice. Data are ex-
pressed as fold-stimulation over control (mean 
SEM, *P  0.0235).
chain with the p85 regulatory domain of PI 3-kinase. diabetic mice (Fig. 6A, lanes 3 and 4 vs. 1 and 2). The
90 kD band likely represents the insulin receptor  chain.This association may occur indirectly through IRS or di-
rectly with the receptor [23]. As shown in Figure 4, there The data suggest autophosphorylation of the insulin re-
ceptor  chain, in addition to phosphorylation of otherwas a 4.24  1.15-fold increase in PI 3-kinase activity in
the insulin receptor  chain immunoprecipitates from proteins that associate with the insulin receptor during
its activation.the renal cortex of diabetic mice relative to the controls
(P  0.0235). In contrast to the renal cortex, PI 3-kinase Tyrosine phosphorylation of the insulin receptor 
chain is an early step in insulin receptor activation. Theactivity was unchanged in the hepatic insulin receptor 
chain immunoprecipitates from diabetic mice (Fig. 5). status of insulin receptor tyrosine phosphorylation was
examined by immunoprecipitating the  chain of theThe cytoplasmic domain of the insulin receptor has
intrinsic tyrosine kinase activity. The possibility of insulin receptor and immunoblotting with an antiphosphotyro-
sine antibody. There was a marked increase in tyrosinereceptor activation in the renal cortex of diabetic mice
was examined further by evaluating the kinase activity phosphorylation of a 90 kD band corresponding to insu-
lin receptor in the renal cortex of diabetic mice comparedof insulin receptor immunoprecipitates. Kinase activity
of the insulin receptor  chain was robustly increased in with control (Fig. 6B). Immunoblotting with antibody
against the insulin receptor  chain confirmed the iden-renal cortical homogenates from diabetic mice compared
with control mice. Increased phosphorylation of several tity of the 90 kD band as insulin receptor  chain. These
data demonstrate insulin receptor activation in the renalproteins, including those of approximate size 110, 90, 70,
60, 45, and 35 kD, was evident in the renal cortex of cortex of mice with diabetes.
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Fig. 5. PI 3-kinase activity in insulin receptor
 chain immunoprecipitates in the liver of db/db
mice with type 2 diabetes. (A) Equal amounts
of (500 g) of liver homogenates from four
control and four diabetic mice were immuno-
precipitated with an antibody against  chain
of the insulin receptor. PI 3-kinase activity was
measured, as described in Figure 2. Each lane
represents an individual animal. (B) Densito-
metric analysis of phosphorylated phosphati-
dylinositol 3-phosphate (PI 3-P). Data are
expressed as fold-stimulation over control
(mean  SEM).
Fig. 6. Insulin receptor activation in the renal cortex of db/db mice with type 2 diabetes.
(A) Equal amounts of renal cortical homogenates from control and diabetic mice were
suspended in RIPA buffer and immunoprecipitated with a rabbit polyclonal antibody against
 chain of the insulin receptor in the presence of protein A-Sepharose beads. The immuno-
beads were suspended in a buffer containing 50 mmol/L HEPES, pH 7.4, 10 mmol/L manga-
nese chloride, and 5 Ci of [32P]ATP. After an incubation of 30 minutes at 30C, the reaction
was stopped by adding an equal volume of 2  sample buffer. Phosphorylated proteins were
resolved on 7.5% SDS-PAGE. Molecular weight markers are shown. (B) Equal amounts of
renal cortical homogenates from control and diabetic mice were immunoprecipitated (IP)
with a rabbit polyclonal antibody against  chain of the insulin receptor (IR). The immuno-
precipitates were separated on 7.5% SDS-PAGE, transferred to nitrocellulose membrane,
and immunoblotted (IB) with an antiphosphotyrosine antibody (P-Tyr-mAb) as described
in the Methods section. The reactive bands were visualized by chemiluminescence. Each lane
represents an individual animal. The membrane was stripped and immunoblotted with the
antibody against insulin receptor  chain to assess loading of samples. The molecular weight
marker is shown. (Lower panel) The nitrocellulose membrane was stripped and reprobed
with antibody against insulin receptor  chain.
Akt/PKB activity is increased in the renal cortex of ERK activity is augmented in the renal cortex of
diabetic micediabetic mice
Akt/PKB is activated downstream of PI 3-kinase when Earlier studies have shown that ERK activity is in-
creased in the glomeruli of rats with type 1 diabetescells are stimulated with hormones and growth factors. It
is activated by phosphorylation by PDK-1 and integrin- [9, 10]. We examined the status of ERK activity in the
renal cortex of mice with type 2 diabetes using an immu-linked kinase after binding to phosphatidylinositol 3
phosphate, a lipid generated by PI 3-kinase [24, 25]. Akt/ nokinase assay. Figure 9 shows that ERK activity was
significantly greater in the renal cortex of mice with dia-PKB activity, measured by an immunokinase assay, was
twofold higher in the renal cortex from diabetic mice betes than in control cortex (7-fold, P  0.001). In the
liver, however, ERK1/2 activity was 50% lower (P than in lean littermate controls (P  0.0003; Fig. 7). Mea-
surement of Akt/PKB activity in the liver homogenates 0.01) in diabetic mice than in lean littermates (Fig. 10),
suggesting the kinase activity is regulated differently inalso showed a similar twofold increase in diabetic mice
compared with littermate controls (P  0.0002; Fig. 8). the liver and the renal cortex in type 2 diabetes.
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Fig. 7. Akt/PKB activity in the renal cortex
of db/db mice with type 2 diabetes. (A) Equal
amounts (500 g) of renal cortical homoge-
nates from lean litter control and diabetic mice
were immunoprecipitated with an anti-Akt anti-
body. Immunoprecipitates were employed in
a kinase reaction using MBP as a substrate.
(Upper panel) A representative autoradiograph
is shown. (Lower panel) An immunoblot of
renal cortical homogenates using anti-Akt anti-
body was performed to assess loading. (B)
Densitometric analysis of phosphorylated MBP
from two independent experiments with a to-
tal of seven control and seven diabetic mice.
Data are expressed as fold-stimulation over
control (mean  SEM, *P  0.0003).
Fig. 8. Akt/PKB activity in the liver of db/db
mice with type 2 diabetes. (A) Equal amounts
(500 g) of liver homogenates from lean litter
control and diabetic mice were employed in
Akt kinase reaction, as described in Figure 7.
(Upper panel) A representative autoradiograph
is shown. (Lower panel) An immunoblot of
liver cortical homogenates using anti-Akt anti-
body was performed to assess loading. (B)
Densitometric analysis of phosphorylated MBP
from two independent experiments with a to-
tal of 8 control and 10 diabetic mice. Data
are expressed as fold-stimulation over control
(mean  SEM, *P  0.0002).
Fig. 9. ERK activity in the renal cortex of
db/db mice with type 2 diabetes. (A) Equal
amounts (500 g) of renal cortical homoge-
nates from lean litter control and diabetic mice
were immunoprecipitated with an anti-ERK
antibody. The immunoprecipitates were em-
ployed in a kinase assay using MBP as a sub-
strate. Phosphorylated MBP was submitted to
electrophoresis on a 15% polyacrylamide gel
and visualized by autoradiography. Each lane
represents data from an individual animal.
(Upper panel) A representative autoradio-
graph from two independent experiments is
shown. (Lower panel) An immunoblot with
anti-ERK antibody was performed to assess
loading. (B) Densitometric analysis of phos-
phorylated MBP from two independent ex-
periments with a total of seven control and
eight diabetic mice. Data are expressed as
fold-stimulation over control (mean  SEM,
*P  0.001).
DISCUSSION activities are increased in the liver in the diabetic mice;
however, unlike the kidney, insulin receptor activationThe following changes occur in db/db mice in the early
does not contribute to the enhanced hepatic PI 3-kinasephase of type 2 diabetes: (1) tyrosine phosphorylation
activity. Also, in contrast to the renal cortex, ERK activ-of renal cortical proteins is increased; (2) activities of PI
ity is reduced in the liver of db/db mice.3-kinase, Akt/PKB, and ERK are stimulated; (3) the
Augmented tyrosine phosphorylation of proteins couldinsulin receptor is activated in the renal cortex of diabetic
mice; (4) similar to the kidney, PI 3-kinase and Akt/PKB be due to increase in the activity of receptor or of nonre-
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Fig. 10. ERK activity in the liver of db/db
mice with type 2 diabetes. (A) Equal amounts
(500 g) of liver homogenates from lean litter
control and diabetic mice were immunopre-
cipitated with an anti-ERK antibody. Assay
for ERK activity was performed as described
in Figure 9. Each lane represents data from
an individual animal. (Upper panel) A repre-
sentative autoradiograph from two indepen-
dent experiments is shown. (Lower panel) An
immunoblot with anti-ERK antibody was per-
formed to assess loading. (B) Densitometric
analysis of phosphorylated MBP from two in-
dependent experiments with a total of seven
control and nine diabetic mice (mean SEM,
*P  0.01).
ceptor tyrosine kinases. Our current study demonstrates of these growth factors has been reported in the kidney
in type 1 diabetes [31, 32]; however, little is known re-that a part of the increased renal cortical PI 3-kinase
activity in the db/db mice is due to insulin receptor activa- garding changes in the activities of any of the aforemen-
tioned renal receptor tyrosine kinases in type 2 diabetes.tion. Insulin receptor-associated PI 3-kinase is differen-
tially regulated between the liver, an organ of insulin An increase in PI 3-kinase activity in antiphosphotyro-
sine immunoprecipitates was seen in both the kidneyresistance, and the kidney. Additionally, the intrinsic
tyrosine kinase activity of the insulin receptor and tyro- and the liver. As the liver is insulin resistant in type 2
diabetes, the augmented hepatic PI 3-kinase activity issine phosphorylation of the insulin receptor  chain is
increased in diabetic mice, demonstrating insulin recep- probably due to mechanisms other than activation of the
hepatic insulin receptor. It is unclear whether any of thetor activation in the renal cortex of db/db mice in the
early phase of diabetes. Thus, our findings suggest that aforementioned receptor tyrosine kinases or nonrecep-
tor kinases are activated in the liver in type 2 diabetes.the kidney is responsive to insulin in the db/db mice.
Renal sensitivity to insulin in type 2 diabetes has not been Phosphatidylinositol 3-kinase catalyzes the phosphor-
ylation of lipid substrates in the D3 position of the inosi-extensively examined. Previous observations suggest that
kidney may not be insulin resistant in type 2 diabetes. tol ring. These phophoinositides are known to bind pro-
teins with pleckstrin homology domains. Important amongUnder physiologic conditions, uric acid reabsorption in
the kidney is stimulated by insulin and is linked to sodium the downstream targets of PI 3-kinase is Akt/PKB, a
serine/threonine kinase with pleckstrin homology do-reabsorption [26]. Elevated plasma uric acid levels are
commonly seen in patients with obesity, type 2 diabetes, main at its amino terminus [24]. Akt/PKB regulates sev-
eral cellular processes of relevance to diabetes, such ashypertriglyceridemia, and essential hypertension (syn-
drome X), conditions characterized by insulin resistance translocation of glucose transporter GLUT4 to the cell
membrane in response to insulin [33]. Additionally, acti-in certain organs and hyperinsulinemia [26]. An increase
in renal uric acid reabsorption significantly correlates vation of Akt/PKB is required for insulin-induced phos-
phorylation of eukaryotic initiation factor 4E (eIF4E)with plasma insulin levels in obesity [27]. Additionally,
exogenous insulin augments renal sodium reabsorption binding protein, 4E-BP1, a repressor of protein transla-
tion [34]. eIF4E activation, the rate-limiting step in pro-in humans with type 2 diabetes to a similar extent as in
nondiabetic controls [28–30]. These observations suggest tein translation, appears to require phosphorylation of
4E-BP1 and dissociation of the complex. In diabetic renalthat the kidney remains sensitive to insulin in this insulin-
resistant state. Conceivably, other functions such as extra- disease, protein translation may be relevant to aug-
mented synthesis of certain proteins that occurs in thecellular matrix synthesis by tubular epithelial cells may
also be insulin sensitive in type 2 diabetes. In this respect, absence of stimulated transcription, for example, 1 and
1 chains of laminin [13], p27kipl cyclin kinase inhibitorthe kidney may be an “innocent bystander,” being sub-
ject to the undesirable actions of insulin in hyperinsulin- [35]. Thus, insulin-regulated Akt/PKB may be involved
in recruiting the eIF4E system to promote translation ofemic states.
Activation of other receptor tyrosine kinases such as proteins such as laminin 1 and 1 chains and p27kipl in
the kidney in type 2 diabetes. Activation of Akt/PKB inreceptors for insulin-like growth factor-I (IGF-I), platelet-
derived growth factor (PDGF), basic fibroblast growth the liver in the db/db mice occurred in the absence of
activation of insulin receptor, suggesting that it was duefactor (bFGF), or G protein-coupled receptors could
also contribute to increased PI 3-kinase activity seen in to other mechanisms. Possible causes include augmented
activity of noninsulin receptor tyrosine kinases (for ex-renal cortex of mice with type 2 diabetes. Overexpression
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ample, PDGF, IGF-I), G protein-coupled receptors, or ogy in insulin resistant states [40], to our knowledge,
our data provide the first evidence of insulin receptordue to mechanisms independent of PI 3-kinase activation
such as in response to cellular stresses (abstract; Gorin activation in renal tissue in type 2 diabetes. The direct
et al, J Am Soc Nephrol 10:468A, 1999). Activation of relevance of changes in activities of individual kinases
Akt need not lead to same phenotypic changes in all to phenotypic manifestations of diabetic nephropathy
tissues and may have different biologic implications for such as hemodynamic changes, matrix accumulation, and
liver and renal cortex in diabetes. In the diabetic kidney, proteinuria remains to be determined. As renal cortex
in light of the ability of Akt to activate protein translation contains several cell types, the role of individual cell
it is possible that Akt is involved in matrix accumulation. types in altered signaling in type 2 diabetes and their state
However, in the diabetic liver, activation of Akt may of differentiation also remain to be determined. Achieving
serve other functions that may be related to glucose and maintaining euglycemia is a difficult goal in the long-
metabolism. In addition, the proximal pathway that re- term management of this disease. Identification of signal-
sults in Akt activation may also influence the biological ing pathways involved in diabetic renal disease should
outcome. Local regulatory factors also may determine facilitate development of novel therapeutic interventions
the phenotypic effect of Akt activation in a tissue-specific that prevent its development and progression.
manner.
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